Diaceutics Financial Statements From 2010 to 2026
| DIUXF Stock | USD 1.37 0.00 0.00% |
Check Diaceutics PLC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Diaceutics PLC's main balance sheet or income statement drivers, such as , as well as many indicators such as . Diaceutics financial statements analysis is a perfect complement when working with Diaceutics PLC Valuation or Volatility modules.
Diaceutics |
Diaceutics PLC Company Operating Margin Analysis
Diaceutics PLC's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Diaceutics PLC Operating Margin | 0 % |
Most of Diaceutics PLC's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Diaceutics PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Diaceutics PLC has an Operating Margin of 0.0012%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Diagnostics & Research industry. The operating margin for all United States stocks is 100.02% lower than that of the firm.
Diaceutics PLC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Diaceutics PLC's current stock value. Our valuation model uses many indicators to compare Diaceutics PLC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Diaceutics PLC competition to find correlations between indicators driving Diaceutics PLC's intrinsic value. More Info.Diaceutics PLC is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.09 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Diaceutics PLC is roughly 10.67 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Diaceutics PLC's earnings, one of the primary drivers of an investment's value.About Diaceutics PLC Financial Statements
Diaceutics PLC stakeholders use historical fundamental indicators, such as Diaceutics PLC's revenue or net income, to determine how well the company is positioned to perform in the future. Although Diaceutics PLC investors may analyze each financial statement separately, they are all interrelated. For example, changes in Diaceutics PLC's assets and liabilities are reflected in the revenues and expenses on Diaceutics PLC's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Diaceutics PLC. Please read more on our technical analysis and fundamental analysis pages.
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom. Diaceutics Plc is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
Other Information on Investing in Diaceutics Pink Sheet
Diaceutics PLC financial ratios help investors to determine whether Diaceutics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diaceutics with respect to the benefits of owning Diaceutics PLC security.